| Net Cash Provided by (Used in) Operating Activities |
$14,699,000 |
USD |
398% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$5,043,000 |
USD |
-192% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,438,000 |
USD |
-22% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
79,978,702 |
shares |
0.42% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,218,000 |
USD |
19944% |
Q2 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$522,000 |
USD |
-8.1% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$2,204,000 |
USD |
14% |
Q1 2025 |
FY 2025 |
| Depreciation |
$1,208,000 |
USD |
12% |
Q2 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$1,438,000 |
USD |
22% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$86,708,000 |
USD |
0.36% |
Q3 2025 |
Q2 2026 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q2 2024 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Current Income Tax Expense (Benefit) |
$4,324,000 |
USD |
-7.8% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$14,472,000 |
USD |
3.3% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Share-based Payment Arrangement, Expense |
$42,000 |
USD |
-39% |
Q2 2025 |
Q1 2026 |
| Interest Expense |
$501,000 |
USD |
-6.9% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Par or Stated Value Per Share |
5 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |